Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Day One Biopharmaceuticals, Inc./ 15-12G

SEC Filing · 15-12G

Day One Biopharmaceuticals, Inc.

SEC Filing

Filed May 4, 2026Accepted May 4, 2026, 6:02 AM EDTCIK 1845337Accession 0001193125-26-202385
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
DAWNNASDAQ · EQUITY · Historical · closed Apr 22, 2026

Recent company filings

  1. SCHEDULE 13G/A - filed by Vestal Point Capital, LP regarding Day One Biopharmaceuticals, Inc.May 15, 2026
  2. 4 filingApr 23, 2026
  3. 4 filingApr 23, 2026
  4. 4 filingApr 23, 2026
  5. 4 filingApr 23, 2026

As-filed source

Primary evidence
As filedOpen full document ↗